Patents by Inventor Randall Mark Jones

Randall Mark Jones has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20180117052
    Abstract: Provided herein are methods that relate to a therapeutic strategy for treatment of cancer, including hematological malignancies. In particular, the methods include administration entospletinib and a Bcl-2 inhibitor, such as venetoclax, navitoclax, and ABT-737.
    Type: Application
    Filed: January 29, 2016
    Publication date: May 3, 2018
    Inventors: Julie A. Di Paolo, Randall Mark Jones, Daniel B. Tumas
  • Publication number: 20160220573
    Abstract: Provided herein are methods that relate to a therapeutic strategy for treatment of cancer, including hematological malignancies. In particular, the methods include administration entospletinib and a Bcl-2 inhibitor, such as venetoclax, navitoclax, and ABT-737.
    Type: Application
    Filed: January 29, 2016
    Publication date: August 4, 2016
    Inventors: Julie A. Di Paolo, Randall Mark Jones, Daniel B. Tumas